Health hub

Life on a GLP-1: Muscle, Protein, Hair Shedding and What Happens When You Stop

The questions that come after the prescription, answered from the trials: how much of the weight lost is lean mass, what protein targets guidelines give, why hair sheds and whether it grows back, and how much weight returns when treatment stops.

By Kymata Labs EditorialLast verified October 11, 2026

Medical review pending. Written by our editorial team from the studies and documents cited below; a credentialed clinician has not reviewed it yet. Educational only, not medical advice.

Key takeaways

  • Roughly 40% of the weight lost on semaglutide and 25% on tirzepatide was lean mass in body-scan substudies, a share similar to diet-based weight loss [1][2].
  • A 2025 joint advisory recommends strength training at least 3 times a week plus 150 minutes of moderate aerobic activity on a GLP-1, and says protein alone is likely inadequate [3].
  • Guidance documents put protein near 1.2 to 1.6 g/kg a day during active weight loss [3][4].
  • Hair shedding on these drugs is linked to weight loss in the labels and is usually telogen effluvium, which is typically reversible [5][6].
  • In withdrawal trials, roughly half to two-thirds of the lost weight returned within about a year of stopping [7][8].

Guides in this hub

  1. Muscle Loss on Semaglutide vs Tirzepatide: What the Body Scans Show, and What Strength Training AddsIn body-scan substudies, roughly 40% of the weight lost on semaglutide and 25% on tirzepatide was lean mass. Pooled trials found lifestyle programs that added resistance training lost a smaller share as lean.
  2. How Much Protein on a GLP-1? What the Joint Advisory and Expert Consensus SayA 2025 joint advisory and a 2026 expert consensus both land near 1.2 to 1.6 g of protein per kg a day during weight loss, with a lower floor for maintenance. Which body weight to multiply by is still unsettled.
  3. Hair Shedding on a GLP-1: Why It Starts Months Later, Whether It Grows Back, and the Ferritin QuestionShedding linked to weight loss is usually telogen effluvium, which is typically reversible: a 2026 review says regrowth tends to become noticeable within 6 to 12 months once the trigger is removed or treated. Iron is recommended when tests show iron-deficiency anemia; its value for shedding otherwise is debated.
  4. Stopping Wegovy or Zepbound: How Much Weight Comes Back, and What Happens to Blood Pressure and Blood SugarWhen tirzepatide was swapped for placebo in SURMOUNT-4, weight rose 14% over the next year; a year after semaglutide stopped in STEP 1, two-thirds of the loss had returned. A 2026 meta-analysis projects cardiometabolic gains fade within about 1.4 years.

What changes on a GLP-1

Semaglutide (Wegovy) and tirzepatide (Zepbound) cut appetite, and both labels say they lower body weight with greater fat loss than lean loss [9][5]. Eating far less can bring lean-mass loss, nutrient shortfalls and hair shedding; this hub gathers the trial data on each.

Start with muscle loss and strength training and protein targets, then hair shedding and regrowth and what happens when you stop.

What happens when treatment stops

In SURMOUNT-4, the weight of people switched from tirzepatide to placebo rose 14.0% over a year, while those who continued kept losing [7]. A year after semaglutide stopped in STEP 1, participants had regained about two-thirds of their loss [8]. Any change to treatment is a decision to make with your prescriber.

For women-specific questions (pregnancy, birth control, menopause), see our women’s GLP-1 hub; for blood sugar and glucose monitors, see metabolic health.

Partners we link to

  • FoundPaid linkWeight care with named board-certified clinicians: brand-name GLP-1 prescriptions (medication billed separately, insurance accepted) or compounded semaglutide and tirzepatide, which are not FDA-approved. LegitScript certified.See Found's weight plans (opens in new tab)

    Partner links may earn us a commission. Learn more

Regulatory and legal notes

  • Compounded semaglutide and tirzepatide are not FDA-approved; the FDA does not review them for safety, effectiveness or quality before they are marketed and says compounded drugs should only be used when an FDA-approved drug cannot meet a patient’s medical need [10].
  • The FDA lists claims that a compounded drug is the same as an FDA-approved drug among its telehealth red flags [10].
  • Wegovy and Zepbound carry a boxed warning about thyroid C-cell tumors seen in rodents; it is unknown whether they cause these tumors in humans [9][5].

References

  1. [1]Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes Obes Metab, 2025. PMID 39996356
  2. [2]Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Diabetes Obes Metab, 2026. PMID 41877354
  3. [3]Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obes Pillars, 2025. PMID 40673264
  4. [4]Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement using a modified Delphi approach. Obes Pillars, 2026. PMID 41502845
  5. [5]ZEPBOUND (tirzepatide) injection: prescribing information (DailyMed, revised 08/2026). U.S. National Library of Medicine (DailyMed), 2026.
  6. [6]Shedding: An updated guide to a common cause of hair loss. Cleve Clin J Med, 2026. PMID 42823125
  7. [7]Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA, 2024. PMID 38078870
  8. [8]Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab, 2022. PMID 35441470
  9. [9]WEGOVY (semaglutide) injection and tablets: prescribing information (DailyMed, revised 06/2026). U.S. National Library of Medicine (DailyMed), 2026.
  10. [10]FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current as of 10/01/2026). U.S. Food and Drug Administration, 2026.

Dietary supplements are not intended to diagnose, treat, cure or prevent any disease, and these statements have not been evaluated by the FDA. Prescription options need a licensed clinician. Talk to your clinician or pharmacist before starting anything new, especially if you take prescription medicines, are pregnant or breastfeeding.

Keep reading: GLP-1 weight loss

GLP-1 weight loss: every page →Cheapest way to get a GLP-1 online →Browse all topics →

Previous in this topicStopping Wegovy or Zepbound: How Much Weight Comes Back, and What Happens to Blood Pressure and Blood SugarWhen tirzepatide was swapped for placebo in SURMOUNT-4, weight rose 14% over the next year; a year after semaglutide stopped in STEP 1, two-thirds of the loss had returned.Next in this topicMuscle Loss on Semaglutide vs Tirzepatide: What the Body Scans Show, and What Strength Training AddsIn body-scan substudies, roughly 40% of the weight lost on semaglutide and 25% on tirzepatide was lean mass.GLP-1 Muscle Loss: How to Protect Lean Mass During Weight LossHow much of the weight lost on semaglutide or tirzepatide is lean mass, what the DXA substudies show, and how protein and resistance training help protect muscle.Creatine monohydrateCreatine is a compound made from amino acids that muscles store as phosphocreatine to recycle energy (ATP) during short, intense effort.Whey protein (and other protein powders)Whey is a complete milk protein sold as powders and drinks; it supplies all essential amino acids used to build and repair muscle.

GLP-1 dose scheduler →GLP-1 cost, dose by dose →